Showing results (511-520 of 525) with videos related to
Sort By:
Pageof 53
Nature Communications|August 3, 2023
Neoadjuvant Afatinib for stage III EGFR-mutant non-small cell lung cancer: a phase II studyDongliang Bian, Liangdong Sun, Junjie Hu, et al.Nature Genetics|December 10, 2024
Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancerYilv Yan, Dongqing Sun, Junjie Hu, et al.Brain, Behavior, and Immunity|August 30, 2023
Early-life noise exposure causes cognitive impairment in a sex-dependent manner by disrupting homeostasis of the microbiota-gut-brain axisXiaofang Li, Bo Fu, Chunli Zhao, et al.Cell Reports. Medicine|June 26, 2026
Multi-omics profiling unveils biological and clinical insights into pulmonary sarcomatoid carcinomaLiangdong Sun, Jue Wang, Yilv Yan, et al.Hepatology (Baltimore, Md.)|April 4, 2017
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesisPin Liu, Mengmeng Ge, Junjie Hu, et al.BMC Medicine|December 29, 2022
Safety and effectiveness of neoadjuvant PD-1 inhibitor (toripalimab) plus chemotherapy in stage II-III NSCLC (LungMate 002): an open-label, single-arm, phase 2 trialXinsheng Zhu, Liangdong Sun, Nan Song, et al.Nature Communications|April 1, 2025
Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trialDongliang Bian, Shuyu Ji, Yue Liu, et al.Cell Discovery|November 25, 2025
Surgery after induced anti-PD-L1 therapy and chemotherapy for stage I‒III small-cell lung cancer: a phase 2 trial (LungMate-005)Fenghuan Sun, Lele Zhang, Liangdong Sun, et al.Nature Structural & Molecular Biology|January 4, 2024
Aurora kinase A-mediated phosphorylation triggers structural alteration of Rab1A to enhance ER complexity during mitosisWei Zhang, Zijian Zhang, Yun Xiang, et al.Journal of Hepatology|July 23, 2017
Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in miceShanshan Zhang, Xinhua Song, Dan Cao, et al.Pageof 53